Global Branded Generics Market Size Study, by Product (Trade Named Generics, Value-Added), by Drug Type (Alkylating Agents, Anti-depressants, Anti-epileptics, Anti-hypertensive, Anti-psychotics, Antimetabolites, Hormones, Lipid Lowering Drugs), by Route of Administration (Oral, Parenteral, Topical), by Indication (Acute & Chronic Pain, Cardiovascular Diseases, Dermatological Diseases, Gastrointestinal Diseases, Neurological Diseases, Oncology), by Distribution Channel (Offline, Online) and Regional Forecasts 2022-2032
Global Branded Generics Market is valued at approximately USD 432.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 14.66% over the forecast period 2024-2032. Branded generics are medications bioequivalent to original innovator drugs and are marketed under a different brand name by another company post-patent expiration. These drugs, formulated using the same active pharmaceutical ingredients (APIs) as the innovator product, must meet similar regulatory requirements for manufacturing, safety, and efficacy standards. The primary growth drivers for the branded generics market include rising consumer awareness of accessible treatment options, increasing healthcare expenditure, and numerous patent expirations on blockbuster drugs.
Furthermore, the significant adoption of value-added branded generics, due to their additional benefits such as combined multiple active ingredients or innovative dosage forms, is driving market growth. For example, Benitek A (Olmesatran in combination with Amlodipine), Nifedical (nifedipine), and Digitek (digoxin) are some value-added products designed to enhance therapeutic effects or reduce side effects. However, the market faces challenges such as stringent regulatory requirements for drug approval and quality control, as well as price erosion due to intense competition among manufacturers.
The route of administration plays a crucial role in the market dynamics, with oral administration being the most common and preferred method due to its convenience and non-invasive nature. Parenteral and topical routes are also significant, particularly for drugs that require quick relief or localized delivery. The indication segment reveals a burgeoning utilization of branded generics for gastrointestinal and neurological diseases, with increasing demand for cost-effective therapies in these areas.
The key regions considered for the global Branded Generics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Branded Generics Market in terms of revenue. The market growth in the region is being attributed to factors including robust healthcare infrastructure and high per capita spending on pharmaceuticals. Also, increasing healthcare expenditure and favorable pricing policies drive market demand. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rising R&D activities, supportive government initiatives, and increasing demand for trade generics.
Major market players included in this report are:
Abbott Laboratories
Ajanta Pharma Ltd.
Alkem Laboratories Ltd.
Amneal Pharmaceuticals LLC
Apotex Inc.
Aspen Pharmacare Holdings Limited
AstraZeneca PLC
Aurobindo Pharma Limited
Bausch Health Companies Inc.
Bristol-Myers Squibb Company
Cipla Limited
Dr. Reddy’s Laboratories Ltd.
Endo International PLC
Eris Lifesciences Limited
Fresenius Kabi AG
The detailed segments and sub-segment of the market are explained below:
By Product:
• Trade Named Generics
• Value-Added
By Drug Type:
• Alkylating Agents
• Anti-depressants
• Anti-epileptics
• Anti-hypertensive
• Anti-psychotics
• Antimetabolites
• Hormones
• Lipid Lowering Drugs
By Route of Administration:
• Oral
• Parenteral
• Topical
By Indication:
• Acute & Chronic Pain
• Cardiovascular Diseases
• Dermatological Diseases
• Gastrointestinal Diseases
• Neurological Diseases
• Oncology
By Distribution Channel:
• Offline
• Online
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
Furthermore, the significant adoption of value-added branded generics, due to their additional benefits such as combined multiple active ingredients or innovative dosage forms, is driving market growth. For example, Benitek A (Olmesatran in combination with Amlodipine), Nifedical (nifedipine), and Digitek (digoxin) are some value-added products designed to enhance therapeutic effects or reduce side effects. However, the market faces challenges such as stringent regulatory requirements for drug approval and quality control, as well as price erosion due to intense competition among manufacturers.
The route of administration plays a crucial role in the market dynamics, with oral administration being the most common and preferred method due to its convenience and non-invasive nature. Parenteral and topical routes are also significant, particularly for drugs that require quick relief or localized delivery. The indication segment reveals a burgeoning utilization of branded generics for gastrointestinal and neurological diseases, with increasing demand for cost-effective therapies in these areas.
The key regions considered for the global Branded Generics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Branded Generics Market in terms of revenue. The market growth in the region is being attributed to factors including robust healthcare infrastructure and high per capita spending on pharmaceuticals. Also, increasing healthcare expenditure and favorable pricing policies drive market demand. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rising R&D activities, supportive government initiatives, and increasing demand for trade generics.
Major market players included in this report are:
Abbott Laboratories
Ajanta Pharma Ltd.
Alkem Laboratories Ltd.
Amneal Pharmaceuticals LLC
Apotex Inc.
Aspen Pharmacare Holdings Limited
AstraZeneca PLC
Aurobindo Pharma Limited
Bausch Health Companies Inc.
Bristol-Myers Squibb Company
Cipla Limited
Dr. Reddy’s Laboratories Ltd.
Endo International PLC
Eris Lifesciences Limited
Fresenius Kabi AG
The detailed segments and sub-segment of the market are explained below:
By Product:
• Trade Named Generics
• Value-Added
By Drug Type:
• Alkylating Agents
• Anti-depressants
• Anti-epileptics
• Anti-hypertensive
• Anti-psychotics
• Antimetabolites
• Hormones
• Lipid Lowering Drugs
By Route of Administration:
• Oral
• Parenteral
• Topical
By Indication:
• Acute & Chronic Pain
• Cardiovascular Diseases
• Dermatological Diseases
• Gastrointestinal Diseases
• Neurological Diseases
• Oncology
By Distribution Channel:
• Offline
• Online
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
CHAPTER 1. GLOBAL BRANDED GENERICS MARKET EXECUTIVE SUMMARY
1.1. Global Branded Generics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Drug Type
1.3.3. By Route of Administration
1.3.4. By Indication
1.3.5. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL BRANDED GENERICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL BRANDED GENERICS MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Increasing Consumer Awareness
3.1.2. Rising Healthcare Expenditure
3.1.3. Increasing Patent Expirations
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements
3.2.2. Price Erosion Due to Competition
3.3. Market Opportunities
3.3.1. Advancements in Pharmaceutical Research
3.3.2. Development of Bioequivalent Products
CHAPTER 4. GLOBAL BRANDED GENERICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)
5.1. Segment Dashboard
5.2. Global Branded Generics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Trade Named Generics
5.2.2. Value-Added
CHAPTER 6. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY DRUG TYPE (2022-2032)
6.1. Segment Dashboard
6.2. Global Branded Generics Market: Drug Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Alkylating Agents
6.2.2. Anti-depressants
6.2.3. Anti-epileptics
6.2.4. Anti-hypertensive
6.2.5. Anti-psychotics
6.2.6. Antimetabolites
6.2.7. Hormones
6.2.8. Lipid Lowering Drugs
CHAPTER 7. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY ROUTE OF ADMINISTRATION (2022-2032)
7.1. Segment Dashboard
7.2. Global Branded Generics Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Parenteral
7.2.3. Topical
CHAPTER 8. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY INDICATION (2022-2032)
8.1. Segment Dashboard
8.2. Global Branded Generics Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Acute & Chronic Pain
8.2.2. Cardiovascular Diseases
8.2.3. Dermatological Diseases
8.2.4. Gastrointestinal Diseases
8.2.5. Neurological Diseases
8.2.6. Oncology
CHAPTER 9. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY DISTRIBUTION CHANNEL (2022-2032)
9.1. Segment Dashboard
9.2. Global Branded Generics Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Offline
9.2.2. Online
CHAPTER 10. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY REGION (2022-2032)
10.1. North America Branded Generics Market
10.1.1. U.S. Branded Generics Market
10.1.1.1. Product breakdown size & forecasts, 2022-2032
10.1.1.2. Drug Type breakdown size & forecasts, 2022-2032
10.1.1.3. Route of Administration breakdown size & forecasts, 2022-2032
10.1.1.4. Indication breakdown size & forecasts, 2022-2032
10.1.1.5. Distribution Channel breakdown size & forecasts, 2022-2032
10.1.2. Canada Branded Generics Market
10.2. Europe Branded Generics Market
10.2.1. U.K. Branded Generics Market
10.2.2. Germany Branded Generics Market
10.2.3. France Branded Generics Market
10.2.4. Spain Branded Generics Market
10.2.5. Italy Branded Generics Market
10.2.6. Rest of Europe Branded Generics Market
10.3. Asia-Pacific Branded Generics Market
10.3.1. China Branded Generics Market
10.3.2. India Branded Generics Market
10.3.3. Japan Branded Generics Market
10.3.4. Australia Branded Generics Market
10.3.5. South Korea Branded Generics Market
10.3.6. Rest of Asia-Pacific Branded Generics Market
10.4. Latin America Branded Generics Market
10.4.1. Brazil Branded Generics Market
10.4.2. Mexico Branded Generics Market
10.4.3. Rest of Latin America Branded Generics Market
10.5. Middle East & Africa Branded Generics Market
10.5.1. Saudi Arabia Branded Generics Market
10.5.2. South Africa Branded Generics Market
10.5.3. Rest of Middle East & Africa Branded Generics Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Abbott Laboratories
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Ajanta Pharma Ltd.
11.3.3. Alkem Laboratories Ltd.
11.3.4. Amneal Pharmaceuticals LLC
11.3.5. Apotex Inc.
11.3.6. Aspen Pharmacare Holdings Limited
11.3.7. AstraZeneca PLC
11.3.8. Aurobindo Pharma Limited
11.3.9. Bausch Health Companies Inc.
11.3.10. Bristol-Myers Squibb Company
11.3.11. Cipla Limited
11.3.12. Dr. Reddy’s Laboratories Ltd.
11.3.13. Endo International PLC
11.3.14. Eris Lifesciences Limited
11.3.15. Fresenius Kabi AG
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
1.1. Global Branded Generics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Drug Type
1.3.3. By Route of Administration
1.3.4. By Indication
1.3.5. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL BRANDED GENERICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL BRANDED GENERICS MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Increasing Consumer Awareness
3.1.2. Rising Healthcare Expenditure
3.1.3. Increasing Patent Expirations
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements
3.2.2. Price Erosion Due to Competition
3.3. Market Opportunities
3.3.1. Advancements in Pharmaceutical Research
3.3.2. Development of Bioequivalent Products
CHAPTER 4. GLOBAL BRANDED GENERICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)
5.1. Segment Dashboard
5.2. Global Branded Generics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Trade Named Generics
5.2.2. Value-Added
CHAPTER 6. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY DRUG TYPE (2022-2032)
6.1. Segment Dashboard
6.2. Global Branded Generics Market: Drug Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Alkylating Agents
6.2.2. Anti-depressants
6.2.3. Anti-epileptics
6.2.4. Anti-hypertensive
6.2.5. Anti-psychotics
6.2.6. Antimetabolites
6.2.7. Hormones
6.2.8. Lipid Lowering Drugs
CHAPTER 7. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY ROUTE OF ADMINISTRATION (2022-2032)
7.1. Segment Dashboard
7.2. Global Branded Generics Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Parenteral
7.2.3. Topical
CHAPTER 8. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY INDICATION (2022-2032)
8.1. Segment Dashboard
8.2. Global Branded Generics Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Acute & Chronic Pain
8.2.2. Cardiovascular Diseases
8.2.3. Dermatological Diseases
8.2.4. Gastrointestinal Diseases
8.2.5. Neurological Diseases
8.2.6. Oncology
CHAPTER 9. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY DISTRIBUTION CHANNEL (2022-2032)
9.1. Segment Dashboard
9.2. Global Branded Generics Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Offline
9.2.2. Online
CHAPTER 10. GLOBAL BRANDED GENERICS MARKET SIZE & FORECASTS BY REGION (2022-2032)
10.1. North America Branded Generics Market
10.1.1. U.S. Branded Generics Market
10.1.1.1. Product breakdown size & forecasts, 2022-2032
10.1.1.2. Drug Type breakdown size & forecasts, 2022-2032
10.1.1.3. Route of Administration breakdown size & forecasts, 2022-2032
10.1.1.4. Indication breakdown size & forecasts, 2022-2032
10.1.1.5. Distribution Channel breakdown size & forecasts, 2022-2032
10.1.2. Canada Branded Generics Market
10.2. Europe Branded Generics Market
10.2.1. U.K. Branded Generics Market
10.2.2. Germany Branded Generics Market
10.2.3. France Branded Generics Market
10.2.4. Spain Branded Generics Market
10.2.5. Italy Branded Generics Market
10.2.6. Rest of Europe Branded Generics Market
10.3. Asia-Pacific Branded Generics Market
10.3.1. China Branded Generics Market
10.3.2. India Branded Generics Market
10.3.3. Japan Branded Generics Market
10.3.4. Australia Branded Generics Market
10.3.5. South Korea Branded Generics Market
10.3.6. Rest of Asia-Pacific Branded Generics Market
10.4. Latin America Branded Generics Market
10.4.1. Brazil Branded Generics Market
10.4.2. Mexico Branded Generics Market
10.4.3. Rest of Latin America Branded Generics Market
10.5. Middle East & Africa Branded Generics Market
10.5.1. Saudi Arabia Branded Generics Market
10.5.2. South Africa Branded Generics Market
10.5.3. Rest of Middle East & Africa Branded Generics Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Abbott Laboratories
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Ajanta Pharma Ltd.
11.3.3. Alkem Laboratories Ltd.
11.3.4. Amneal Pharmaceuticals LLC
11.3.5. Apotex Inc.
11.3.6. Aspen Pharmacare Holdings Limited
11.3.7. AstraZeneca PLC
11.3.8. Aurobindo Pharma Limited
11.3.9. Bausch Health Companies Inc.
11.3.10. Bristol-Myers Squibb Company
11.3.11. Cipla Limited
11.3.12. Dr. Reddy’s Laboratories Ltd.
11.3.13. Endo International PLC
11.3.14. Eris Lifesciences Limited
11.3.15. Fresenius Kabi AG
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
LIST OF TABLES
TABLE 1. Global Branded Generics Market, report scope
TABLE 2. Global Branded Generics Market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Branded Generics Market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 4. Global Branded Generics Market estimates & forecasts by Drug Type 2022-2032 (USD Billion)
TABLE 5. Global Branded Generics Market by Route of Administration, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Branded Generics Market by Indication, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Branded Generics Market by Distribution Channel, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Branded Generics Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Branded Generics Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Branded Generics Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Branded Generics Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Branded Generics Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
TABLE 1. Global Branded Generics Market, report scope
TABLE 2. Global Branded Generics Market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Branded Generics Market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 4. Global Branded Generics Market estimates & forecasts by Drug Type 2022-2032 (USD Billion)
TABLE 5. Global Branded Generics Market by Route of Administration, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Branded Generics Market by Indication, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Branded Generics Market by Distribution Channel, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Branded Generics Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Branded Generics Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Branded Generics Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Branded Generics Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Branded Generics Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Branded Generics Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Branded Generics Market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
LIST OF FIGURES
FIG 1. Global Branded Generics Market, research methodology
FIG 2. Global Branded Generics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Branded Generics Market, key trends 2023
FIG 5. Global Branded Generics Market, growth prospects 2022-2032
FIG 6. Global Branded Generics Market, porters 5 force model
FIG 7. Global Branded Generics Market, PESTEL analysis
FIG 8. Global Branded Generics Market, value chain analysis
FIG 9. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Branded Generics Market, regional snapshot 2022 & 2032
FIG 15. North America Branded Generics Market 2022 & 2032 (USD Billion)
FIG 16. Europe Branded Generics Market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Branded Generics Market 2022 & 2032 (USD Billion)
FIG 18. Latin America Branded Generics Market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Branded Generics Market 2022 & 2032 (USD Billion)
FIG 20. Global Branded Generics Market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
------------
FIG 1. Global Branded Generics Market, research methodology
FIG 2. Global Branded Generics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Branded Generics Market, key trends 2023
FIG 5. Global Branded Generics Market, growth prospects 2022-2032
FIG 6. Global Branded Generics Market, porters 5 force model
FIG 7. Global Branded Generics Market, PESTEL analysis
FIG 8. Global Branded Generics Market, value chain analysis
FIG 9. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Branded Generics Market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Branded Generics Market, regional snapshot 2022 & 2032
FIG 15. North America Branded Generics Market 2022 & 2032 (USD Billion)
FIG 16. Europe Branded Generics Market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Branded Generics Market 2022 & 2032 (USD Billion)
FIG 18. Latin America Branded Generics Market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Branded Generics Market 2022 & 2032 (USD Billion)
FIG 20. Global Branded Generics Market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
------------
